Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
NCT: NCT07599982 · RECRUITING
Brief Summary
A 13-week multi-center single-arm trial, preceded by a 2-week standard therapy phase, will be conducted to assess the safety of MODI, an insulin titration algorithm, in adults with type 1 diabetes (T1D) who use multiple daily insulin injections (MDI), or with type 2 diabetes (T2D) who use MDI, basal insulin only, or who are candidates to initiate basal insulin, in conjunction with continuous glucose monitoring (CGM).
Frequently Asked Questions
What is Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes?
Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes is a clinical trial registered under NCT07599982. Current status: RECRUITING.
What is the status of NCT07599982?
The current status of NCT07599982 (Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes) is: RECRUITING.
When did Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes start?
Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes started on 2026-05.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.